Artroscan s.r.o.
- Address
- Trebovicka 5114/106, 722 00 Trebovice, Czechia
Digestive System Diseases
At Artroscan s.r.o., the gastroenterology team is running studies focused on ulcerative colitis and primary biliary cholangitis, with additional interest in related liver and bowel conditions. The research is centered on understanding how new and existing treatments can better control symptoms, improve disease markers, and support long-term management in gastroenterology.
- Evaluating treatment effectiveness for moderately to severely active ulcerative colitis
- Studying new options for primary biliary cholangitis and liver health
- Assessing long-term safety and improvement in clinical outcomes for digestive system diseases
This work includes both symptom-focused care and monitoring of biochemical indicators, reflecting a strong interest in practical, patient-relevant advances in gastroenterology.
Immune System Diseases
The site also contributes to research in immune-mediated diseases, especially psoriatic arthritis, axial spondyloarthritis, and Sjögren's disease. These trials are designed to test whether newer therapies can reduce inflammation, improve daily function, and offer better control of chronic autoimmune conditions.
- Investigating better treatment options for psoriatic arthritis and related joint inflammation
- Exploring therapies for axial spondyloarthritis and ankylosing spondylitis
- Evaluating approaches for Sjögren's disease and broader autoimmune disorders
The research aims to improve both symptom relief and long-term disease control, helping advance care for people living with chronic immune system diseases.
Musculoskeletal Diseases
Musculoskeletal research at this Czechia-based site includes studies in rheumatoid arthritis, juvenile idiopathic arthritis, osteoporosis, and knee osteoarthritis. The trials are examining whether new therapies can ease pain, protect joints, strengthen bone health, and improve mobility in people affected by long-term bone and joint conditions.
- Testing treatments for rheumatoid arthritis and other inflammatory joint diseases
- Studying bone-strengthening strategies in osteoporosis
- Evaluating pain relief and functional improvement in knee osteoarthritis
This area of research combines symptom management with broader efforts to support quality of life and preserve physical function across a range of musculoskeletal diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Ipsen Bioscience Inc.1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ipsen Bioscience Inc.2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Artroscan s.r.o.
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Pharmacokinetic and Safety Study of Bimekizumab via Different Routes of Administration in Adults with Chronic Cutaneous Inflammation | UCB Biopharma | Phase I | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bezafibrate | 2 | Unknown | 2019-09-20 | 2025-04-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.